CIPLA
Active threads
Cipla profit drops 39% in Q1
Cipla reported a 39% year-over-year decline in profits to Rs 789 crore for the first quarter. The company's stock fell after the earnings miss and sharp margin contraction.
Morgan Stanley cuts Cipla target to ₹1,218, retains underweight
3 Min Read Shares of Cipla Ltd. were trading in the red on Friday, September 4, after Morgan Stanley retained its Underweight rating on the drugmaker with a target price of ₹1,218, making it the second-lowest target among analysts who track the stock. The brokerage's target implies a downside potential of 12.4% downside from Thursday's closing price.
UltraTech's ₹1,800 Crore Wire Entry Slashes Polycab, KEI Shares
UltraTech's launch of its 'Ultravolt' cables and wires business has triggered a sharp sell-off in cable stocks, with Polycab and KEI Industries falling up to 8% on de-rating fears. Analysts are split: JPMorgan sees a buying opportunity at lower valuations, while others question the impact on UltraTech's own shares. The market is also reacting to UltraTech's plans to scale its EV truck fleet, which has given its shares a slight edge.
Cipla partners Qilu Pharma for Keytruda biosimilar in US
2 Min Read Drug firm Cipla Ltd on Thursday (September 3) announced that its wholly owned subsidiary Invagen Pharmaceuticals Inc has entered into a strategic partnership with Qilu Pharmaceutical Co. Ltd for the exclusive licensing and supply of QL2107, a biosimilar to Keytruda (pembrolizumab), in the United States. Under the agreement, Qilu will be responsible for the development, regulatory registration and supply of QL2107, while Cipla USA Inc.
Cipla launches live blog tracking daily price movement
Cipla Share Price Live Updates: Cipla's Price Movement Today 28 Aug 2026 | 10:35:30 AM IST Cipla share price live updates Stay informed with the Cipla Stock Liveblog, your comprehensive resource for real-time updates and in-depth analysis of a leading stock. Get the latest details on Cipla, including: Last traded price 1412.9, Market capitalization: 114205.09, Volume: 75356, Price-to-earnings ratio 33.88, Earnings per share 41.72.
Intelligence feed
No articles in the last 24 hours.